Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

11
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
11
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

11
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

20
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
20
Autoimmune Disorders01:29

Autoimmune Disorders

544
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
544
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
Glaucoma: Overview01:25

Glaucoma: Overview

638
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
638

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

PD1<sup>+</sup> TIGIT<sup>+</sup> CD4<sup>+</sup> T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis.

RMD open·2026
Same author

Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort.

RMD open·2026
Same author

Update on the Aetiopathogenesis of Sjögren Disease: From Interferon Signaling to Epithelial Dysfunction.

Journal of clinical medicine·2026
Same author

Early-life animal and farming exposures and the risk of rheumatoid arthritis: findings from the E3N French cohort study.

RMD open·2025
Same author

Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum.

RMD open·2025

Related Experiment Video

Updated: Jul 29, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

2.5K

Expert Perspective: Challenges in Sjögren's Disease.

Gaetane Nocturne1, Xavier Mariette1

  • 1Department of Rheumatology, Université Paris-Saclay, INSERM UMR1184, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, Paris, France.

Arthritis & Rheumatology (Hoboken, N.J.)
|May 25, 2023
PubMed
Summary
This summary is machine-generated.

Managing Sjögren

More Related Videos

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

501

Related Experiment Videos

Last Updated: Jul 29, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

2.5K
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

501

Area of Science:

  • Rheumatology and Immunology
  • Autoimmune Disease Research

Background:

  • Sjögren's disease presents heterogeneous clinical manifestations.
  • Prognostic markers are crucial for adapting patient follow-up.
  • Currently, no validated treatments exist for Sjögren's disease.

Purpose of the Study:

  • To review current challenges in Sjögren's disease management.
  • To highlight the need for prognostic markers and validated treatments.
  • To discuss expert recommendations and future research directions.

Main Methods:

  • Review of existing literature on Sjögren's disease management.
  • Analysis of expert opinions and international recommendations.
  • Assessment of current research trends and future therapeutic prospects.

Main Results:

  • Heterogeneity of clinical presentation complicates management.
  • Lack of validated treatments necessitates expert-guided recommendations.
  • Active research suggests potential for future effective therapies.

Conclusions:

  • Effective management of Sjögren's disease requires addressing its heterogeneous nature and identifying prognostic markers.
  • International expert recommendations provide current guidance in the absence of validated treatments.
  • Ongoing research offers promise for the development of novel therapeutic strategies for Sjögren's disease.